Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The gut microbiome in Alzheimer’s disease: what we know and what remains to be explored
Sidhanth Chandra, Sangram S. Sisodia, Robert Vassar
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 128

Showing 1-25 of 128 citing articles:

Emerging diagnostics and therapeutics for Alzheimer disease
Wade Self, David M. Holtzman
Nature Medicine (2023) Vol. 29, Iss. 9, pp. 2187-2199
Closed Access | Times Cited: 160
Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases
Jian Sheng Loh, Wen Qi Mak, Li Tan, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 154
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 58
Recent advances in Alzheimer’s disease: Mechanisms, clinical trials and new drug development strategies
Jifa Zhang, Yinglu Zhang, Jiaxing Wang, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 54
Role of Gut Microbiota in Neurological Disorders and Its Therapeutic Significance
Prabhakar Tiwari, Rekha Dwivedi, Manisha Bansal, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 4, pp. 1650-1650
Open Access | Times Cited: 43
Efficacy of Probiotic Supplements on Brain-Derived Neurotrophic Factor, Inflammatory Biomarkers, Oxidative Stress and Cognitive Function in Patients with Alzheimer’s Dementia: A 12-Week Randomized, Double-Blind Active-Controlled Study
Yu-Chieh Hsu, Yen-Yu Huang, Shin‐Yu Tsai, et al.
Nutrients (2023) Vol. 16, Iss. 1, pp. 16-16
Open Access | Times Cited: 36
Neuropathogenesis-on-chips for neurodegenerative diseases
Sarnai Amartumur, Huong Mai Nguyen, Thuy Huynh, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 17
Curcumin Mitigates the High-Fat High-Sugar Diet-Induced Impairment of Spatial Memory, Hepatic Metabolism, and the Alteration of the Gut Microbiome in Alzheimer’s Disease-Induced (3xTg-AD) Mice
Gopal Lamichhane, Jing Liu, Su‐Jeong Lee, et al.
Nutrients (2024) Vol. 16, Iss. 2, pp. 240-240
Open Access | Times Cited: 16
Gut microbiome-targeted therapies for Alzheimer’s disease
Tao Zhang, Guangqi Gao, Lai‐Yu Kwok, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 32
Transmission of Alzheimer’s disease-associated microbiota dysbiosis and its impact on cognitive function: evidence from mice and patients
Yiying Zhang, Yuan Shen, Ning Liufu, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 10, pp. 4421-4437
Open Access | Times Cited: 28
The gut microbiome regulates astrocyte reaction to Aβ amyloidosis through microglial dependent and independent mechanisms
Sidhanth Chandra, Antonio Di Meco, Hemraj B. Dodiya, et al.
Molecular Neurodegeneration (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 23
Role of Tau Protein in Neurodegenerative Diseases and Development of Its Targeted Drugs: A Literature Review
J Yang, Weijia Zhi, Lifeng Wang
Molecules (2024) Vol. 29, Iss. 12, pp. 2812-2812
Open Access | Times Cited: 11
Gut microbiota-host lipid crosstalk in Alzheimer’s disease: implications for disease progression and therapeutics
Yaxi Luo, Ling-Ling Yang, Xiu‐Qing Yao
Molecular Neurodegeneration (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 10
Alzheimer’s Disease: Models and Molecular Mechanisms Informing Disease and Treatments
Kaden Nystuen, Shannon M. McNamee, Monica Akula, et al.
Bioengineering (2024) Vol. 11, Iss. 1, pp. 45-45
Open Access | Times Cited: 9
Gut microbiota and its metabolites in Alzheimer’s disease: from pathogenesis to treatment
Xinfu Zou, Guoqiang Zou, Xinyan Zou, et al.
PeerJ (2024) Vol. 12, pp. e17061-e17061
Open Access | Times Cited: 9
Alzheimer’s disease and drug delivery across the blood–brain barrier: approaches and challenges
Iram Iqbal, Fatima Saqib, Zobia Mubarak, et al.
European journal of medical research (2024) Vol. 29, Iss. 1
Open Access | Times Cited: 8
Early modulation of the gut microbiome by female sex hormones alters amyloid pathology and microglial function
Piyali Saha, Ian Q. Weigle, Nicholas Slimmon, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Exploring the gut microbiota and its potential as a biomarker in gliomas
Dana Aljarrah, Naima Chalour, Amine Zorgani, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 173, pp. 116420-116420
Open Access | Times Cited: 6
The link between gut microbiome and Alzheimer's disease: From the perspective of new revised criteria for diagnosis and staging of Alzheimer's disease
Yuan Liang, Congcong Liu, Manman Cheng, et al.
Alzheimer s & Dementia (2024) Vol. 20, Iss. 8, pp. 5771-5788
Open Access | Times Cited: 6
Taming neuroinflammation in Alzheimer's disease: The protective role of phytochemicals through the gut−brain axis
Yoonsu Kim, Jinkyu Lim, Jisun Oh
Biomedicine & Pharmacotherapy (2024) Vol. 178, pp. 117277-117277
Closed Access | Times Cited: 6
Hotspots and research trends of gut microbiome in polycystic ovary syndrome: a bibliometric analysis (2012–2023)
Ruishan Wu, Zhensheng Mai, Xiaoyan Song, et al.
Frontiers in Microbiology (2025) Vol. 15
Open Access
Iron Homeostasis Dysregulation, Oro-Gastrointestinal Microbial Inflammatory Factors, and Alzheimer’s Disease: A Narrative Review
Agata Kuziak, Piotr B. Heczko, Agata Pietrzyk, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 122-122
Open Access
Gut microbiota in Alzheimer’s disease: Understanding molecular pathways and potential therapeutic perspectives
Simone Lista, Antonio Munafò, Filippo Caraci, et al.
Ageing Research Reviews (2025) Vol. 104, pp. 102659-102659
Closed Access
Oral Administration of Lactobacillus gasseri and Lacticaseibacillus rhamnosus Ameliorates Amyloid Beta (Aβ)-Induced Cognitive Impairment by Improving Synaptic Function Through Regulation of TLR4/Akt Pathway
H Choi, Hyo Lim Lee, In Young Kim, et al.
Antioxidants (2025) Vol. 14, Iss. 2, pp. 139-139
Open Access
Investigating gut alterations in Alzheimer’s disease: In-depth analysis with micro- and nano-3D X-ray phase contrast tomography
Francesca Palermo, N. Marrocco, Letizia Dacomo, et al.
Science Advances (2025) Vol. 11, Iss. 5
Open Access
Page 1 - Next Page

Scroll to top